Research is being conducted on the safety of migraine medications during pregnancy, with some studies investigating the potential risks of certain medications, such as anti-CGRPs and triptans. The relationship between prenatal exposure to these medications and neurodevelopmental outcomes in offspring is being explored, with conflicting findings reported. The treatment of migraines during pregnancy is a complex issue, with various considerations and options being reviewed by medical professionals.